Novel cell signaling pathway could be targeted against aggressive pancreatic cancers

Researchers at the Johns Hopkins Kimmel Cancer Center identified a novel cell signaling pathway that potentially could be targeted in therapy for patients with aggressive pancreatic cancers.

Related Keywords

National Institutes Of Health ,Maryland ,United States ,Elizabeth Jaffee ,Liping Li ,Liz Luo ,Jung Hyun Kim ,Kathy Gabrielson ,Johns Hopkins ,Tait Huso ,Linda Resar ,Gongbo Guo ,Lionel Chia ,Shuai ,Liliana Herrera ,Laura Wood ,Sophia Chen ,Emily Henderson ,Bowen Wang ,Karen Reddy ,Mohammad Heydarian ,High Mobility Group ,Sol Goldman Pancreatic Cancer Research Center ,Maryland Stem Cell Research Fund ,Allegheny Health Network ,Johns Hopkins Kimmel Cancer Center ,Lingling Xian ,Woo Jung Sung ,Shun Ishiyama ,Lei Zheng ,Leslie Cope ,National Institutes ,Sol Goldman Pancreatic Cancer Research ,Cancer ,Fell ,Cell Signaling ,Gene ,Ene Expression ,Genes ,Growth Factor ,Laboratory ,Medicine ,Pancreatic Cancer ,Protein ,Research ,Na ,Ignaling Pathway ,Humor ,